About Gnosis Pharmaceutical
Gnosis Pharmaceutical is a Healthcare company based in Delhi (India) founded in 2007. It manufactures pharmaceutical drugs including capsules, syrups, and ointments for health needs. It operates on a B2B and B2C model. The company has 309 employees. Its Indian entity Gnosis Pharmaceuticals Private Limited reported revenue of ₹88.76 Cr. Gnosis Pharmaceutical offers products and services including Kainosis Tablets, Intel Syrup, Cygnus Capsules, and Tycoon Cream. Its focus areas include Pharmaceuticals, OTC Products, Consumer Health and Drug Manufacturing.
Company details
Gnosis Pharmaceuticals Pvt. Ltd. produces a range of pharmaceutical products such as tablets, capsules, syrups, and creams through its divisions like Kainosis and Intel. The company operates from locations in Delhi, Chandigarh, and Himachal Pradesh, focusing on quality manufacturing and contract services. It serves domestic and export markets with innovative healthcare solutions, emphasizing research and global standards.
- Headquarters Delhi, India
- Employees 309
- SectorsHealthcare
- Email••••••••
- Website gnosispharma.com
- Social Facebook YouTube
- Legal Name Gnosis Pharmaceuticals Private Limited
- Date of Incorporation 17 Mar, 2005
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹88.76 Cr
FY 2024 · +18% YoY
- Net Profit₹1.08 Cr
FY 2024 · 1% margin
- EBITDA₹4.29 Cr
FY 2024 · 5% margin
- Employee Count309
Associated legal entities of Gnosis Pharmaceutical
Gnosis Pharmaceutical operates through Gnosis Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Gnosis Pharmaceuticals Private Limited CIN U24231DL2005PTC134162 | Active | 17 Mar 2005 | New Delhi, Delhi | ₹88.8 Cr | 309 | 3 | View details |
Products & Services of Gnosis Pharmaceutical
Gnosis Pharmaceutical offers a comprehensive portfolio of products and services, including Kainosis Tablets, Intel Syrup, Cygnus Capsules, and Tycoon Cream.
Tablets for general health and treatment purposes.
Syrups designed for various medical conditions.
Capsules providing essential health benefits.
Creams for skin care and topical applications.
Apps and channels of Gnosis Pharmaceutical
its YouTube channel GNOSIS PHARMACEUTICALS PVT LTD has 88 subscribers.
Board of directors of Gnosis Pharmaceuticals Private Limited (Gnosis Pharmaceutical)
Gnosis Pharmaceuticals Private Limited is the primary company behind Gnosis Pharmaceutical. The board of Gnosis Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Ramesh Khurana, appointed in 2011. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ramesh Khurana DIN 00353177 | Director | 26 Nov 2011 | 14 yrs 11 mo | Gnosis Pharmaceuticals Private Limited |
| Rajesh Kumar Khurana DIN 01093846 | Director | 26 Nov 2011 | 14 yrs 11 mo | Gnosis Pharmaceuticals Private Limited |
| Surendra Kumar Yadav DIN 10666353 | Director | 26 Jun 2024 | 2 yrs 4 mo | Gnosis Pharmaceuticals Private Limited |
Financials of Gnosis Pharmaceutical
Figures of Gnosis Pharmaceuticals Private Limited, the primary company behind Gnosis Pharmaceutical, for FY 2024. Revenue was ₹88.76 Cr (+18% year on year). Net profit was ₹1.08 Cr (1% margin). EBITDA was ₹4.29 Cr (5% margin). Revenue has grown at a compounded annual rate of +23% over three years and +12% over five years.
- ₹88.76 CrRevenue · FY 2024 · +18% YoY
- ₹1.08 CrNet profit · 1% margin
- ₹4.29 CrEBITDA · 5% margin
- ₹1.57 CrPaid-up capital
- 309Employees (provident fund records)
- +23%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Gnosis Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Gnosis Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Gnosis Pharmaceutical
Gnosis Pharmaceutical was founded in 2007.
Gnosis Pharmaceutical is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Gnosis Pharmaceutical has 309 employees.
The primary company behind Gnosis Pharmaceutical, Gnosis Pharmaceuticals Private Limited, reported revenue of ₹88.76 Cr for FY 2024, up 18% year on year.
Gnosis Pharmaceuticals Pvt. Ltd. produces a range of pharmaceutical products such as tablets, capsules, syrups, and creams through its divisions like Kainosis and Intel. The company operates from locations in Delhi, Chandigarh, and Himachal Pradesh, focusing on quality manufacturing and contract services. It serves domestic and export markets with innovative healthcare solutions, emphasizing research and global standards.
Gnosis Pharmaceutical offers Kainosis Tablets, Intel Syrup, Cygnus Capsules, and Tycoon Cream.
Gnosis Pharmaceutical operates through Gnosis Pharmaceuticals Private Limited.
The legal entities of Gnosis Pharmaceutical currently have 3 directors, including Ramesh Khurana, Rajesh Kumar Khurana, Surendra Kumar Yadav.